We used
polypropylenimine dendrimers for delivering a 31 nt triplex-forming
oligonucleotide (ODN) in breast, prostate and
ovarian cancer cell lines, using 32P-labeled ODN.
Dendrimers enhanced the uptake of ODN by approximately 14-fold in MDA-MB-231
breast cancer cells, compared with control ODN uptake.
Dendrimers exerted their effect in a concentration- and molecular weight-dependent manner, with generation 4 (G-4)
dendrimer having maximum efficacy. A similar increase in ODN uptake was found with MCF-7 and SK-BR-3 (breast), LNCaP (prostate) and SK-OV-3 (
ovarian) cancer cells. The
dendrimers had no significant effect on cell viability at concentrations at which maximum ODN uptake occurred. [3H]
Thymidine incorporation showed that complexing the ODN with G-4 significantly increased the growth-inhibitory effect of the ODN. Western blot analysis showed a significant 65% reduction of c-myc
protein level in ODN-G-4 treated cells compared with that of ODN-treated/control cells. Gel electrophoretic analysis showed that ODN remained intact in cells even after 48 h of treatment. The hydrodynamic radii of nanoparticles formed from ODN in the presence of the
dendrimers were in the range of 130-280 nm, as determined by dynamic
laser light scattering. Taken together, our results indicate that
polypropylenimine dendrimers might be useful vehicles for delivering therapeutic
oligonucleotides in
cancer cells.